Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tropical Melhoramento & Genética (TMG) is a leading Brazilian plant breeding company specializing in the genetic improvement of soybean, cotton, and corn. The company develops and commercializes elite cultivars with advanced traits for disease resistance and yield, with flagship technologies such as Inox Technology® for Asian soybean rust resistance. TMG operates state-of-the-art research facilities across Brazil and has rapidly expanded its scientific workforce and R&D investments, supporting the global demand for grains and fibers sustainably[1][4][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tropical Melhoramento & Genética.